These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 27930363

  • 1. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients.
    Diamantopoulos MA, Kontos CK, Kerimis D, Papadopoulos IN, Scorilas A.
    Clin Chem Lab Med; 2017 May 01; 55(5):737-747. PubMed ID: 27930363
    [Abstract] [Full Text] [Related]

  • 2. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
    Kerimis D, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A.
    Clin Biochem; 2017 Apr 01; 50(6):285-292. PubMed ID: 27939727
    [Abstract] [Full Text] [Related]

  • 3. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
    Kontos CK, Tsiakanikas P, Avgeris M, Papadopoulos IN, Scorilas A.
    Mol Diagn Ther; 2017 Aug 01; 21(4):453-464. PubMed ID: 28405803
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.
    Rapti SM, Kontos CK, Papadopoulos IN, Scorilas A.
    Tumour Biol; 2016 Sep 01; 37(9):11815-11824. PubMed ID: 27044381
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. miR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma.
    Adamopoulos PG, Kontos CK, Rapti SM, Papadopoulos IN, Scorilas A.
    Int J Oncol; 2015 Feb 01; 46(2):849-59. PubMed ID: 25420464
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P, Padilla D, Villarejo P, Palomino T, Nieto P, Menéndez JM, Rodríguez-Montes JA.
    J Surg Oncol; 2013 Nov 01; 108(6):369-73. PubMed ID: 23970420
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.
    Takahashi Y, Iwaya T, Sawada G, Kurashige J, Matsumura T, Uchi R, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.
    Ann Surg Oncol; 2014 Jan 01; 21(1):205-12. PubMed ID: 24046120
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M, Shen D, Wang W, Xian J.
    Int J Clin Exp Pathol; 2015 Jan 01; 8(5):5542-8. PubMed ID: 26191262
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MicroRNA-7 Is Associated with Malignant Potential and Poor Prognosis in Human Colorectal Cancer.
    Nagano Y, Toiyama Y, Okugawa Y, Imaoka H, Fujikawa H, Yasuda H, Yoshiyama S, Hiro J, Kobayashi M, Ohi M, Araki T, Inoue Y, Mohri Y, Kusunoki M.
    Anticancer Res; 2016 Dec 01; 36(12):6521-6526. PubMed ID: 27919977
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.